Literature DB >> 16511565

Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.

Young-Gun Yoo1, Gu Kong, Mi-Ock Lee.   

Abstract

The expression of metastasis-associated protein 1 (MTA1) correlates well with tumor metastases; however, the associated molecular mechanism is not fully understood. Here, we explored the possibility of cross-talk between MTA1 and hypoxia-inducible factor-1alpha (HIF-1alpha), a key regulator of angiogenic factors. We observed that the expression of MTA1 was strongly induced under hypoxia in breast cancer cell lines such as MCF-7 and MDA-MB-231. When MTA1 was overexpressed, the transcriptional activity and stability of HIF-1alpha protein were enhanced. MTA1 and HIF-1alpha are physically associated in vivo and they were localized completely in the nucleus when coexpressed. MTA1 induced the deacetylation of HIF-1alpha by increasing the expression of histone deacetylase 1 (HDAC1). MTA1 counteracted to the action of acetyltransferase, ARD1, and it did not stabilize the HIF-1alpha mutant that lacks the acetylation site, K532R. These results indicate that acetylation is the major target of MTA1/HDAC1 function. Collectively, our data provide evidence of a positive cross-talk between HIF-1alpha and MTA1, which is mediated by HDAC1 recruitment, and indicate a close connection between MTA1-associated metastasis and HIF-1-induced tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511565      PMCID: PMC1422150          DOI: 10.1038/sj.emboj.7601025

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation.

Authors:  Joo Won Jeong; Moon Kyoung Bae; Mee Young Ahn; Se Hee Kim; Tae Kwon Sohn; Myung Ho Bae; Mi Ae Yoo; Eun Joo Song; Kong Joo Lee; Kyu Won Kim
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

2.  Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.

Authors:  Toshio Kuwai; Yasuhiko Kitadai; Shinji Tanaka; Seiji Onogawa; Norimasa Matsutani; Eijiro Kaio; Masanori Ito; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

3.  Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation.

Authors:  Chunhong Yan; Heng Wang; Yasushi Toh; Douglas D Boyd
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

Review 4.  Clinical development of histone deacetylase inhibitors as anticancer agents.

Authors:  Daryl C Drummond; Charles O Noble; Dmitri B Kirpotin; Zexiong Guo; Gary K Scott; Christopher C Benz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

5.  Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

Authors:  Keith B Glaser; Michael J Staver; Jeffrey F Waring; Joshua Stender; Roger G Ulrich; Steven K Davidsen
Journal:  Mol Cancer Ther       Date:  2003-02       Impact factor: 6.261

6.  Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing.

Authors:  Eric Metzen; Utta Berchner-Pfannschmidt; Petra Stengel; Jan H Marxsen; Ineke Stolze; Matthias Klinger; Wei Qi Huang; Christoph Wotzlaw; Thomas Hellwig-Bürgel; Wolfgang Jelkmann; Helmut Acker; Joachim Fandrey
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

7.  Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.

Authors:  Matthew Stoner; Bradley Saville; Mark Wormke; Dana Dean; Robert Burghardt; Stephen Safe
Journal:  Mol Endocrinol       Date:  2002-10

8.  MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.

Authors:  Amjad H Talukder; Sandip K Mishra; Mahitosh Mandal; Seetharaman Balasenthil; Sonal Mehta; Aysegul A Sahin; Christopher J Barnes; Rakesh Kumar
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

Review 9.  Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.

Authors:  Garth L Nicolson; Akihiro Nawa; Yasushi Toh; Shigeki Taniguchi; Katsuhiko Nishimori; Amr Moustafa
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more
  75 in total

1.  Targeted genes and interacting proteins of hypoxia inducible factor-1.

Authors:  Wei Liu; Shao-Ming Shen; Xu-Yun Zhao; Guo-Qiang Chen
Journal:  Int J Biochem Mol Biol       Date:  2012-05-31

2.  Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.

Authors:  Young-Joo Jin; Young-Hwa Chung; Jeong A Kim; Won Hyung Park; Danbi Lee; Dong Dae Seo; Soo Hyung Ryu; Myoung Kuk Jang; Eunsil Yu; Young Joo Lee
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

Review 3.  MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.

Authors:  Rajesh R Singh; Rakesh Kumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

4.  Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth.

Authors:  Mizuho Ishikawa; Mitsuhiko Osaki; Makoto Yamagishi; Kunishige Onuma; Hisao Ito; Futoshi Okada; Hideya Endo
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

5.  Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.

Authors:  Sharareh Siamakpour-Reihani; Kouros Owzar; Chen Jiang; Peter M Scarbrough; Oana I Craciunescu; Janet K Horton; Holly K Dressman; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2015-03-26       Impact factor: 3.914

6.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

Review 7.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17

8.  Roles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumor growth and metastasis.

Authors:  Mi-Ni Lee; Shi-Nai Lee; Se-Hee Kim; Bora Kim; Bo-Kyung Jung; Ji Hae Seo; Ji-Hyeon Park; Jae-Hoon Choi; Sun Hee Yim; Mi-Ran Lee; Jong-Gil Park; Ji-Young Yoo; Jeong Hun Kim; Seung-Taek Lee; Hwan-Mook Kim; Sandra Ryeom; Kyu-Won Kim; Goo Taeg Oh
Journal:  J Natl Cancer Inst       Date:  2010-03-01       Impact factor: 13.506

9.  Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.

Authors:  Sung-Hye Kim; Hyun-Jin Kang; Hyelin Na; Mi-Ock Lee
Journal:  Breast Cancer Res       Date:  2010-04-13       Impact factor: 6.466

10.  Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.

Authors:  Scott S Terhune; Nathaniel J Moorman; Ileana M Cristea; John Paul Savaryn; Christian Cuevas-Bennett; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.